Anthony D Ho Selected Research

Anthony D Ho Research Topics

Disease

50	Multiple Myeloma 01/2018 - 09/2002
45	Neoplasms (Cancer) 01/2021 - 01/2002
23	Leukemia 01/2021 - 01/2002
22	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 12/2003
18	Lymphoma (Lymphomas) 01/2020 - 01/2002
15	Immunoglobulin Light-chain Amyloidosis 01/2018 - 12/2003
13	Amyloidosis 01/2018 - 12/2004
11	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 12/2003
11	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 01/2005
10	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018 - 05/2006
9	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 09/2016 - 01/2002
9	Chromosome Aberrations (Chromosome Abnormalities) 01/2016 - 05/2008
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 12/2003
7	Infections 09/2017 - 08/2003
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 12/2002
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 01/2002
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2018 - 05/2008
6	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 01/2002
6	Body Weight (Weight, Body) 10/2017 - 01/2002
6	Paraproteinemias (Monoclonal Gammopathy) 01/2012 - 12/2003
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 07/2009
4	Disease Progression 06/2018 - 12/2005
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2014 - 04/2007
4	Hodgkin Disease (Hodgkin's Disease) 02/2013 - 04/2006
4	Breast Neoplasms (Breast Cancer) 04/2006 - 01/2002
3	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 09/2005
3	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2004
3	Blast Crisis (Blast Phase) 12/2018 - 04/2007
3	Testicular Neoplasms (Testicular Cancer) 10/2017 - 04/2008
3	Autoimmune Diseases (Autoimmune Disease) 07/2016 - 07/2004
3	Residual Neoplasm 04/2016 - 06/2006
3	Hairy Cell Leukemia 01/2016 - 05/2003
3	Inflammation (Inflammations) 06/2010 - 03/2008
3	Pathologic Complete Response 10/2009 - 12/2003
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2009 - 01/2007
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 07/2018 - 11/2010
2	Chylous Ascites 09/2016 - 08/2009
2	Weight Loss (Weight Reduction) 10/2015 - 05/2015

Drug/Important Bio-Agent (IBA)

20	Rituximab (Mabthera)FDA Link 09/2017 - 01/2002
14	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
12	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 10/2006
12	Melphalan (Alkeran)FDA LinkGeneric 11/2017 - 12/2004
11	AntigensIBA 11/2017 - 11/2004
11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2017 - 01/2003
10	Lenalidomide (CC 5013)FDA Link 01/2018 - 01/2009
9	Amyloid (Amyloid Fibrils)IBA 01/2018 - 12/2003
7	SteroidsIBA 01/2018 - 08/2011
6	Bortezomib (Velcade)FDA Link 01/2018 - 01/2010
6	purineIBA 01/2015 - 05/2003
5	CytokinesIBA 12/2018 - 09/2002
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2017 - 08/2006
5	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2016 - 04/2006
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2016 - 10/2006
5	plerixafor FDA Link 02/2015 - 08/2006
5	Pentostatin (Nipent)FDA LinkGeneric 01/2015 - 05/2003
5	Imatinib Mesylate (Gleevec)FDA Link 06/2014 - 12/2002
5	Thalidomide (Thalomid)FDA Link 03/2013 - 09/2002
4	Chimeric Antigen ReceptorsIBA 01/2020 - 10/2016
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 10/2010
4	Pharmaceutical PreparationsIBA 01/2018 - 05/2003
4	Phosphotransferases (Kinase)IBA 01/2018 - 09/2006
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2017 - 05/2008
4	Biological ProductsIBA 11/2015 - 07/2002
4	DNA (Deoxyribonucleic Acid)IBA 11/2015 - 01/2002
4	Glucose (Dextrose)FDA LinkGeneric 07/2009 - 03/2004
3	EnzymesIBA 06/2018 - 06/2010
3	RNA (Ribonucleic Acid)IBA 01/2018 - 03/2004
3	Cisplatin (Platino)FDA LinkGeneric 10/2017 - 10/2006
3	Aldehyde DehydrogenaseIBA 01/2017 - 12/2009
3	Vincristine (Oncovin)FDA LinkGeneric 08/2015 - 05/2008
3	Alkylating AgentsIBA 01/2015 - 04/2006
3	Etoposide (VP 16)FDA LinkGeneric 08/2014 - 04/2007
3	Peptides (Polypeptides)IBA 01/2013 - 04/2006
3	Arginine (L-Arginine)FDA Link 01/2013 - 06/2010
3	ArginaseIBA 01/2013 - 09/2006
3	pericentrinIBA 06/2009 - 11/2003
2	Core Binding Factors (Core-Binding Factor)IBA 01/2022 - 01/2017
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2019 - 08/2003
2	Surface Antigens (Surface Antigen)IBA 01/2018 - 06/2007
2	Monoclonal AntibodiesIBA 01/2018 - 08/2003
2	Transaminases (Aminotransferases)IBA 11/2017 - 10/2010
2	Bendamustine Hydrochloride FDA Link 01/2017 - 12/2016
2	Azacitidine (5 Azacytidine)FDA Link 01/2017 - 08/2014
2	Methotrexate (Mexate)FDA LinkGeneric 01/2016 - 03/2005

Therapy/Procedure

54	Therapeutics 01/2021 - 09/2002
49	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
47	Stem Cell Transplantation 01/2021 - 01/2002
10	Transplantation 01/2022 - 12/2003
10	Immunotherapy 06/2018 - 11/2004
7	Hematopoietic Stem Cell Transplantation 01/2020 - 12/2003
6	Radiotherapy 10/2017 - 03/2004
6	Autologous Transplantation 01/2016 - 01/2007
4	Hematopoietic Stem Cell Mobilization 11/2017 - 12/2014
3	Cell Transplantation 01/2022 - 03/2016
3	Salvage Therapy 01/2016 - 10/2006
3	Aftercare (After-Treatment) 07/2013 - 05/2003
2	Homologous Transplantation 01/2019 - 01/2015
2	Immunomodulation 01/2018 - 01/2015
2	Photopheresis 01/2018 - 03/2015
2	Heart Transplantation (Grafting, Heart) 11/2017 - 10/2009